Institution statistics

FUNDACION PARA LA INVESTIGACION MEDICA APLICADA - Spain 

Ranking results:

Past rankings:
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:600-700
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2013
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:300-400
Total Number of Projects:66
Total Project Funding:400-500
Partner Constancy:58
Project Leadership Index:69
Diversity Index:61
2012
Criterium:Position:
Overall Score:700-800
Total Project Funding per Partner:500-600
Total Number of Projects:68
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:41
2011
Criterium:Position:
Overall Score:400-500
Total Project Funding per Partner:400-500
Total Number of Projects:500-600
Total Project Funding:500-600
Networking Rank (Reputation):800-900
Partner Constancy:> 1000
Project Leadership Index:100-200
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:700-800
Total Number of Projects:900-1000
Total Project Funding:600-700
Networking Rank (Reputation):900-1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:500-600
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:900-1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 42
As coordinator: 2
As participant: 26
Sole participant: 14
Coordinator / Participant Ratio: 0.08*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 333.865 14.056.649 1.034.395 2 3
2018 2.158.122 1.279.782 2.405.995 2 1
2017 0 2.512.169 247.873 1
2015 5.920.122 0 1.360.122 2
2014 223.002 2.415.767 643.502 1 1
2013 849.197 27.470.147 2.596.453 4 4
2012 0 3.197.783 1.733.149 3
2011 3.575.220 20.928.350 2.472.606 3 3
2010 0 2.999.500 172.500 1
2008 0 19.202.710 1.022.942 3
2007 0 2.250.000 562.500 1
2006 160.000 12.494.460 774.838 2 2
2004 0 2.493.900 138.550 1
2002 0 3.045.025 203.002 1
2001 0 3.830.276 319.190 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE8
MEDIZINISCHE HOCHSCHULE HANNOVER6
UNIVERSITEIT MAASTRICHT6
UNIVERSIDAD DE NAVARRA5
INSERM TRANSFERT4
KATHOLIEKE UNIVERSITEIT LEUVEN4
MOSAIQUES DIAGNOSTICS4
UNIVERSITY COLLEGE LONDON4
UNIVERSITY OF GLASGOW4
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE3
CHARITE UNIVERSITAETSMEDIZIN BERLIN3
HOSPICES CANTONAUX CHUV3
KLINIKUM DER UNIVERSITAET ZU KOELN3
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN3
LUNDS UNIVERSITET3
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA3
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN3
ACS BIOMARKER BV2
CF CONSULTING FINANZIAMENTI UNIONE EUROPEA2
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS2
DEUTSCHES KREBSFORSCHUNGSZENTRUM2
DIGNA BIOTECH SL2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
FIRALIS SAS2
FONDATION TRANSPLANTATION2
GENIBET BIOPHARMACEUTICALS2
INSTITUT GUSTAVE ROUSSY2
INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA2
ISTITUTO AUXOLOGICO ITALIANO2
ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI2
MEDIZINISCHE UNIVERSITAET WIEN2
RANDOX CLINICS LIMITED2
STICHTING KATHOLIEKE UNIVERSITEIT2
THE UNIVERSITY OF LIVERPOOL2
UNIVERSITA DEGLI STUDI DI BRESCIA2
UNIVERSITA DEGLI STUDI DI MILANO2
UNIVERSITA DEGLI STUDI DI MILANO BICOCCA2
UNIVERSITAETSKLINIKUM HEIDELBERG2
UNIVERSITAT AUTONOMA DE BARCELONA2
UNIVERSITY OF LEICESTER2
UNIVERSITY OF WALES CARDIFF2
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACADEMISCH ZIEKENHUIS BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACADEMISCH ZIEKENHUIS LEIDEN1
ADURO BIOTECH EUROPE BV1
ALBERT LUDWIGS UNIVERSITAET FREIBURG1
AMSTERDAM MOLECULAR THERAPEUTICS BV1
ARTTIC1
ASSOCIATION EUROPEENNE POUR LA MALADIE DE PARKINSON1
ASSOCIAZIONE HAND IN HAND1
AZIENDA OSPEDALIEROUNIVERSITARIA DI PARMA1
BAYERISCHE JULIUSMAXIMILIANSUNIVERSITAET WUERZBURG1
BELFAST CITY HOSPITAL TRUST1
BIOINVENT INTERNATIONAL AB1
BIONEER1
BRAINS UNLIMITED BV / TRADE NAME SCANNEXUS1
CANCER RESEARCH UK1
CANISIUS WILHELMINA ZIEKENHUIS1
CARDIOMYOPATHY UK1
CELLULAR THERAPEUTICS LIMITED1
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE NANCY1
CENTRE HOSPITALIER UNIVERSITAIRE DE NANCY1
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS1
CENTRO NACIONAL DE INVESTIGACIONESCARDIOVASCULARES CARLOS III1
CHARLES UNIVERSITY IN PRAGUE1
CLINICA MEDITERRANEA1
CONSIGLIO NAZIONALE DELLE RICERCHE1
CROWDHELIX LIMITED1
EMERGENTEC BIODEVELOPMENT1
EMORY UNIVERSITY NON PROFIT CORP1
ERASMUS UNIVERSITY MEDICAL CENTER ROTTERDAM1
EVOTEC NEUROSCIENCES1
FACULTY OF MEDICINE/UNIVERSITY HOSPITAL GOETTINGEN1
FLANDERS INTERUNIVERSITY INSTITUTE FOR BIOTECHNOLOGY VZW1
FONDAZIONE CAVALIERI OTTOLENGHI1
FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMOURI1
FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA1
FONDAZIONE SANTA LUCIA1
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE1
FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS1
FUNDACION DE INVESTIGACION DEL HOSPITAL CLINICO UNIVERSITARIO OF VALENCIA1
FUNDACION INVESTIGACION DEL HOSPITAL CLINICO UNIVERSITARIO OF VALENCIA1
FUNDACION PARA LA INVESTIGACION DEL HOSPITAL CLINICO DE LA COMUNITAT VALENCIANA FUNDACION INCLIVA1
FUNDACION PUBLICA MIGUEL SERVET1
FYZIOLOGICKY USTAV AKADEMIE VED CESKE REPUBLIKY VEREJNA VYZKUMNA INSTITUCE1
GENOPOIETIC1
GERMAN CANCER RESEARCH CENTER1
GLYCOCHECK BV1
GLYCOTOPE1
GOETEBORGS UNIVERSITET1
GREENPHARMA S A1
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT1
HEALTH PROTECTION AGENCY1
HELLENIC PASTEUR INSTITUTE1
HOPITAL NECKERENFANTS MALADES1
HOSPITAL CLINIC BARCELONA1
HOSPITAL CLINIC PROVINCIAL DE BARCELONA1
HOSPITAL UNIVERSITARIO LA PAZ1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INLECOM INNOVATION ASTIKI MI KERDOSKOPIKI ETAIREIA1
Constancy:

Total number of partners:289

Partner loyalty:
Frequent Partner: (> 2 projects): 69
Rare Partner: 220

Frequent / Rare Partner Ratio: 0.31

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES23
RTD HORIZONTAL TOPICS10
SOCIAL AND ECONOMIC CONCERNS4
PROTECTING MAN AND HIS ENVIRON1
INDUSTRY AND TECHNOLOGY1

Project overview:

Start dateProjectacronymrolefundingpartners
2020-07-01Synapses between Leukaemia and its Neighbouring Cells SyLeNCecoordinator160.9321
2020-05-01DevelOpmeNt of Cancer RNA TherapEutics cONCReTEparticipant2.060.80017
2020-03-01Elucidating transcriptional rewiring on hematological malignancies via computational methods LINKERcoordinator172.9321
2020-01-01MiCrovasculaR rarefaction in vascUlar Cognitive Impairement and heArt faiLure CRUCIALparticipant6.000.00012
2020-01-01COMORBIDITY MECHANISMS OF ANXIETY AND PARKINSON’S DISEASE AND-PDparticipant5.995.84911
2018-06-01Training Network for the education of the next generation scientist in targeting the supressive capacity of regulatory T-cells specifically within tumours Tumor-Treg-Targetingparticipant1.279.7824
2018-04-01Investigating the role of the long noncoding transcriptome in chromatin replication NonChroRepcoordinator2.000.0001
2018-02-15Advancing cancer immunotherapy using natural killer cells for hematological and metastatic cancers CINKcoordinator158.1221
2017-01-01European Network on Anti-Cancer Immuno-Therapy Improvement by modification of CAR and TCR Interactions and Nanoscale Geometry EN_ACTI2NGparticipant2.512.16913
2015-12-01Characterization of Key Epigenetic Targets in Hepatic Fibrosis and Hepatocellular Carcinoma Development. Generation of New Antifibrotic and Antitumoral Drugs. TARGEPILIVERcoordinator170.1221
2015-09-01Professional cross-priming for ovary and prostate cancer PROCROPcoordinator5.750.0007
2014-06-01New experimental therapeutic approaches for Parkinson’s disease by direct DA neuronal reprogramming REPROPARKparticipant2.415.7672
2014-04-01Interspecies endotheliarization for organ xenotransplantation INTEREXTcoordinator223.0021
2013-11-01Immunostimulatory Agonist antibodies for Cancer Therapy IACTparticipant5.995.74710
2013-11-01ROLE OF THE TRANSCRIPTION FACTOR FOXP1 IN B CELL FUNCTION AND LYMPHOMAGENESIS LYMFOXP1coordinator230.0371
2013-10-01The European non-coding RNA network RNATRAINparticipant3.474.40011
2013-10-01The role of miRNAs in KRAS-driven Non-Small Cell Lung Cancer KRASMIRcoordinator100.0001
2013-09-01Role of DNA methylation in the regulation of lincRNAs in Hematological Malignancies LINCMHEMcoordinator352.8241
2013-09-01Targeting cardiac fibrosis for heart failure treatment FIBRO-TARGETSparticipant6.000.00011
2013-03-01The roles of juvenil NMDA receptors in synapse maturation and elimination and their association with cognition NMDAR-SYNPRUNcoordinator166.3361
2013-02-01Heart OMics in AGEing HOMAGEparticipant12.000.00018
2012-11-01"From Brain Gene Transfer Towards Gene Therapy: Pharmacological Assessment of AAV, CAV and LVV" BRAINVECTORSparticipant1.597.78312
2012-09-01Supply-rate depression as endogenous anti-epileptic mechanism ENDOGENOUS AEDparticipant100.0002
2012-01-01Functional and Mecahnistic Roles of Large Intergenic Non-coding RNAs in Cancer CANCERLINCparticipant1.500.0001
2011-12-01Markers for Sub-Clinical Cardiovascular Risk Assessemnt EU-MASCARAparticipant5.990.88016
2011-11-01Evaluation of metastatic and angiogenic potential of cancer stem-like cells in distinct mouse models for lung and liver metastasis Metastasiscoordinator167.0661
2011-04-01NEW ADVANCED VACCINES IN CHRONIC HEPATITIS B NAVICHEBcoordinator100.0001
2011-01-01The MEtabolic Road to DIAstolic Heart Failure MEDIAparticipant11.971.72121
2011-01-01Determining (epi)genetic therapeutic signatures for improving lung cancer prognosis CURELUNGparticipant2.965.74911
2011-01-01Augmenting PBGD expression in the liver as a Novel Gene therapy for Acute Intermittent Porphyria AIPGENEcoordinator3.308.1547
2010-11-01Host and viral factors in acute hepatitis C HepaCuteparticipant2.999.50017
2008-11-01Restorative plasticity at corticostriatal excitatory synapses REPLACESparticipant4.219.76612
2008-10-01Nonhuman adenovirus vectors for gene transfer to the brain BRAINCAVparticipant2.984.99911
2008-06-01European Network for Cell Imaging and Tracking Expertise ENCITEparticipant11.997.94530
2007-01-01Development of an effective RNA interference-based anti-HIV-1 therapy using an SV40-derived gene transfer vector HIVSTOPparticipant2.250.0004
2006-11-01Integrated genomics, clinical research and care in hypertension INGENIOUS HYPERCAREparticipant10.000.00033
2006-01-02Role of NMDA receptor endocytic trafficking in the development of neural circuitry NR3coordinator80.0001
2006-01-02Three-dimensional genomic analysis of cancer progression 3DCAPcoordinator80.0001
2006-01-01Targeted Herpesvirus-derived Oncolytic Vectors for Liver cancer European Network THOVLENparticipant2.494.4608
2004-07-01European Mantle Cell Lymphoma Network: Tranlational determination of molecular prognostic factors and pharmacogenomics in a European interdisciplinary collaboration EUROPEAN MCL NETWORKparticipant2.493.90018
2002-11-01The use of molecular biomarkers in early lung cancer detection (EARLY LUNG CANCER) EARLY LUNG CANCERparticipant3.045.02515
2001-10-01Early diagnosis of Alzheimer's disease and related dementia DIADEMparticipant3.830.27612

Alias institution names:
  • FUNDACION PARA LA INVESTIGACION MEDICA APLICADA
  • FUNDACION PARA LA INVESTIGACION MEDICA APLICADA FIMA

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum